Study title:
Thomson B et al Avramis V, Douglas JG, Loken MR, Hawkins DS.Toxicity and efficacy of intensive chemotherapy for children with acute lymphoblastic leukemia (ALL) after first bone marrow or extramedullary relapse Pediatr Blood Cancer. 2004 Oct;43(5):571-9Thomson B et al Avramis V, Douglas JG, Loken MR, Hawkins DS.Toxicity and efficacy of intensive chemotherapy for children with acute lymphoblastic leukemia (ALL) after first bone marrow or extramedullary relapse Pediatr Blood Cancer. 2004 Oct;43(5):571-9
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Neoplasms [C04]
|
Brands: Please see report, Please see report, Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: CYCLOPHOSPHAMIDE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
Y
|